Sandostatin therapy in patients with chronic sarcoidosis

Sandostatin therapy in patients with chronic sarcoidosis

Authors

  • Wilhelmina MC Timmermans Erasmus Medical Center
  • Jan AM van Laar Erasmus Medical Center
  • Virgil ASH Dalm Erasmus Medical Center
  • Boen LR Kam Erasmus Medical Center
  • P Martin van Hagen Erasmus Medical Center
  • Paul LA van Daele Erasmus Medical Center

Keywords:

Sarcoidosis, Somatostatin analogue, Therapeutics

Abstract

Not available

Downloads

Published

30-01-2018

Issue

Vol. 34 No. 3 (2017)

Section

Letter to Editor

License

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

1.
Timmermans WM, van Laar JA, Dalm VA, Kam BL, van Hagen PM, van Daele PL. Sandostatin therapy in patients with chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2018 Jan. 30 [cited 2025 Aug. 21];34(3):269-71. Available from: https://mail.mattioli1885journals.com/index.php/sarcoidosis/article/view/6143
Crossref
Scopus
Google Scholar
Europe PMC